Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.

Previous studies of sporadic inclusion body myositis (sIBM) have shown a strong association with HLA-DR3 and other components of the 8.1 ancestral haplotype (AH) (HLA-A1, B8, DR3), where the susceptibility locus has been mapped to the central major histocompatibility complex (MHC) region between HLA-DR and C4. Here, the association with HLA-DR3 and other genes in the central MHC and class II region was further investigated in a group of 42 sIBM patients and in an ethnically similar control group (n = 214), using single-nucleotide polymorphisms and microsatellite screening. HLA-DR3 (marking DRB1*0301 in Caucasians) was associated with sIBM (Fisher's test). However, among HLA-DR3-positive patients and controls, carriage of HLA-DR3 without microsatellite and single-nucleotide polymorphism alleles of the 8.1AH (HLA-A1, B8, DRB3*0101, DRB1*0301, DQB1*0201) was marginally less common in patients. Patients showed no increase in carriage of the 18.2AH (HLA-A30, B18, DRB3*0202, DRB1*0301, DQB1*0201) or HLA-DR3 without the central MHC of the 8.1AH, further arguing against HLA-DRB1 as the direct cause of susceptibility. Genes between HLA-DRB1 and HOX12 require further investigation. BTL-II lies in this region and is expressed in muscle. Carriage of allele 2 (exon 6) was more common in patients. BTL-II(E6)*2 is characteristic of the 35.2AH (HLA-A3, B35, DRB1*01) in Caucasians and HLA-DR1, BTL-II(E6)*2, HOX12*2, RAGE*2 was carried by several patients. The 8.1AH and 35.2AH may confer susceptibility to sIBM independently or share a critical allele.

[1]  L. Rowen,et al.  BTL-II : a polymorphic locus with homology to the butyrophilin gene family, located at the border of the major histocompatibility complex class II and class III regions in human and mouse , 2000, Immunogenetics.

[2]  F. Mastaglia,et al.  Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects , 2003, Muscle & nerve.

[3]  M. Smikle,et al.  HLA‐DRB3 *0101 is associated with Graves' disease in Jamaicans , 2001, Clinical endocrinology.

[4]  F. Christiansen,et al.  The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases , 1999, Immunological reviews.

[5]  M. Dalakas,et al.  HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies , 1998, Journal of Neuroimmunology.

[6]  S. Ohno,et al.  Genetic polymorphisms of the major histocompatibility complex-encoded antigen-processing genes TAP and LMP in sarcoidosis. , 1996, Human immunology.

[7]  C. Witt,et al.  Localization of central MHC genes influencing type I diabetes. , 2001, Human immunology.

[8]  F L Mastaglia,et al.  HLA associations with inclusion body myositis , 1994, Clinical and experimental immunology.

[9]  F. Breedveld,et al.  The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. , 2001, Human immunology.

[10]  Reinhard Hohlfeld,et al.  T-cell heterogeneity in muscle lesions of inclusion body myositis , 1998, Journal of Neuroimmunology.

[11]  M. Dalakas.  Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.

[12]  F. Christiansen,et al.  The central MHC gene IKBL carries a structural polymorphism that is associated with HLA-A3,B7,DR15 , 1999, Immunogenetics.

[13]  A. Schmidt,et al.  Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. , 2002, Advanced drug delivery reviews.

[14]  L. Hood,et al.  Activated Notch4 Inhibits Angiogenesis: Role of β1-Integrin Activation , 2002, Molecular and Cellular Biology.

[15]  C. Witt,et al.  Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex , 1999, Immunogenetics.

[16]  M. Dalakas,et al.  Inclusion Body Myositis: New Concepts , 1993, Seminars in neurology.

[17]  Gen Tamiya,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999 .

[18]  W. Engel,et al.  Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy. , 1998, The American journal of pathology.

[19]  M. Lan,et al.  The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. , 2000, The Journal of clinical endocrinology and metabolism.

[20]  F L Mastaglia,et al.  Prevalence of sporadic inclusion body myositis in Western Australia , 2000, Muscle & nerve.